Mirogabalin

Another Name
LuciMirog, Mirogabalin 5 mg, neuropathic pain treatment
Indications
LuciMirog is indicated for the treatment of neuropathic pain, including peripheral neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia.
Reg No
12 L 1426/26
Inspection No
3347-25
dosage form:Tablets
Specs:5mg* 100Tablets
Indate:2 Years
Date:2026-3-12 Views:538

LuciMirog (Mirogabalin) 5mg

EACH LUCIMIROG TABLET CONTAINS: Mirogabalin besilate equivalent to Mirogabalin ………… 5 mg

INDICATION:

LuciMirog is indicated for the treatment of neuropathic pain, including peripheral neuropathic pain associated with diabetic peripheral neuropathy and postherpetic neuralgia.

DOSAGE AND USE:

Recommended starting dose: 5 mg orally twice daily.

After 1 week, the dose may be increased to 10 mg twice daily depending on the patient’s response and tolerability.

Tablets should be swallowed whole with water and may be taken with or without food.

Dose adjustment may be required in patients with renal impairment.

STORAGE:

Store at 20°C to 25°C (68°F to 77°F).

Excursions permitted to 15°C to 30°C (59°F to 86°F).

Keep the medicine out of reach of children.

Manufactured and Marketed by: LUCIUS PHARMACEUTICALS (LAO) CO., LTD

No. 26, Thongmang Village, Xaythany District, Vientiane Capital, Laos

Original article, if reprinted, please indicate the link to this article: https://lucius-pharmaceuticals.com/drug/mirogabalin/

Related News